Research, News & Discoveries

One of the monoclonal antibodies in the therapeutic Evusheld has been computationally redesigned to restore its action against Omicron variants of the virus that causes COVID-19. Read More

Meet Stephen Doster, ‪associate program director of academic and educational support‬ in Basic Sciences. Read More

Within the intellectual powerhouse that is Vanderbilt University and Vanderbilt University Medical Center thrives a group of doctors, engineers, computer scientists and others who also are visionaries, inventors and entrepreneurs. Several of these change-makers also donate their time and expertise through the Vanderbilt Innovation Ambassadors Program to help colleagues in their departments recognize and pursue the world-altering potential of their own ideas. Read More

Seminar series by biomedical scientists from across the nation brings research collaboration opportunities to trainees and students from Nashville universities. Read More

The Cell Imaging Shared Resource launches an image contest to highlight the stunning scientific images captured with CISR instruments. Cash prizes will be awarded to winning submissions. Read More

Benjamin P. Brown, assistant professor of pharmacology, and colleagues in the departments of molecular physiology and biophysics, pharmacology, and chemistry, have determined that AlphaFold2 can be used to generate approximations of relative conformational preferences of proteins, which will help researchers better understand a protein’s structure and function across a range of conditions and mutational states. Read More

Ken Lau, professor of cell and developmental biology, and colleagues have laid out the principles governing the biology of early, precancerous lesions, which are different from the principles that govern cancers. Their authoritative perspective was published in Cancer Discovery in April 2024. Read More

The Vanderbilt Center for Addiction Research hosted Science Day on April 18. The annual event, which started in 2017, featured the latest research in addiction, including investigations into alcohol, opioids, and stimulants. Read More

Vanderbilt’s cell and developmental biology department is the third-most NIH-funded in the nation. Biochemistry, pharmacology, and molecular physiology and biophysics are in the top 15. Read More

While at Vanderbilt, Williams will work with Hinton to identify novel treatment targets for chronic kidney disease, a disease most caused by hypertension and diabetes. Williams will continue to actively engage in outreach activities, professional service, and research endeavors to uplift underrepresented minority students in the scientific community. Read More